Okay, let's tackle this question about preimplantation genetic diagnosis. First, I need to recall what PGD is. From my studies, PGD is a technique used in in vitro fertilization to screen embryos for genetic abnormalities before implantation. The core concept here is reproductive genetics and its application in preventing genetic disorders.

The correct answer should define PGD accurately. Let me think about the options. PGD is specifically for detecting genetic issues in embryos created through IVF. It's different from prenatal diagnosis, which is done after implantation. So, if any option mentions prenatal, that's wrong. Also, PGD is used for couples at high risk of passing on genetic diseases.

Now, the other options might confuse PGD with other techniques like karyotype analysis or amniocentesis. PGD is done pre-implantation, whereas amniocentesis is during pregnancy. Another possible wrong option could be about diagnosing existing embryos, but PGD is about screening before implantation.

The clinical pearl here is that PGD is a proactive step in IVF to avoid chromosomal abnormalities, which is high-yield for exams. I should make sure to highlight that distinction from other diagnostic methods. The correct answer should clearly state that PGD is for screening embryos before they're implanted, using IVF. So, the answer is the option that defines it as such.

**Core Concept**
Preimplantation genetic diagnosis (PGD) is a reproductive technology used to screen embryos for genetic abnormalities *before* implantation during in vitro fertilization (IVF). It targets couples at high risk of transmitting inherited disorders, enabling selection of genetically normal embryos.

**Why the Correct Answer is Right**
PGD involves biopsying a single-cell or blastocyst-stage embryo, followed by genetic testing (e.g., PCR, FISH, or NGS) to detect chromosomal or monogenic mutations. This prevents implantation of embryos with conditions like Down syndrome or cystic fibrosis. It is distinct from prenatal diagnosis (e.g., amniocentesis), which occurs after implantation.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect if it describes prenatal testing (e.g., amniocentesis). PGD occurs *pre-implantation*, not during pregnancy.
**Option B:** Incorrect if it refers to diagnosing existing embryos in the uterus. PGD is used for *in vitro* embryos created via IVF.
**Option C:** Incorrect if it confuses PGD with karyotype analysis of somatic cells. PGD specifically targets embryos for genetic screening.

**Clinical Pearl / High-Yield Fact**
PGD is *not* a standalone infertility treatment but an adjunct to IVF for couples with known genetic risks (e.g., balanced translocations, autosomal dominant disorders). It reduces the risk of transmitting inherited conditions but does not eliminate all possibilities (e.g., de novo mutations).

**Correct Answer: C. Genetic screening of embryos before implantation in IVF cycles**

✓ Correct Answer: B. Identify genetic abnormalities in eggs or embryos prior to their transfer